# FDA Inspection 1302460 - Biomat USA, Inc. - January 22, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/79cb581e-99fb-43fd-9337-fe14491a50f8
Source feed: FDA_Inspections

> FDA Inspection 1302460 for Biomat USA, Inc. on January 22, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302460
- Company Name: Biomat USA, Inc.
- Inspection Date: 2026-01-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1302460 - 2026-01-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/348fec63-3a3f-4bf2-b418-02725d138836)

Company: https://www.keypedia.com/companies/biomat-usa-inc/6b022a34-ab67-4fd0-b43d-2de60f7c5371